QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026)

QuidelOrtho (QDEL) reported Cash from Financing Activities of $37.6 million for Q1 2026, up 113.64% on a YoY basis from $17.6 million in Q1 2025, and up 438.74% sequentially from -$11.1 million in Q4 2025.

QuidelOrtho (QDEL) Cash from Financing Activities (2021 - 2026) Analysis & Trends

QuidelOrtho (QDEL) has 6 years of Cash from Financing Activities data on file, last reported at $37.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities rose 113.64% year-over-year to $37.6 million; the trailing twelve-month figure through Mar 2026 stood at $175.8 million (up 107.07% YoY), and the FY2025 full-year result was $155.8 million, up 219.26% from the prior year.
  • Cash from Financing Activities grew to $37.6 million in Q1 2026, from -$11.1 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $424.2 million in Q1 2023 to a low of -$99.7 million in Q3 2023.
  • A 5-year average of $26.5 million and a median of -$11.1 million in 2025 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities plunged 1652.94% in 2023 and jumped 274.9% in 2025, its largest moves.
  • Tracing QDEL's Cash from Financing Activities over 5 years: stood at -$3.4 million in 2022, then slumped by 1600.0% to -$57.8 million in 2023, then fell by 19.2% to -$68.9 million in 2024, then jumped by 83.89% to -$11.1 million in 2025, then surged by 438.74% to $37.6 million in 2026.
  • Business Quant data shows QDEL's Cash from Financing Activities at $37.6 million in Q1 2026, -$11.1 million in Q4 2025, and $46.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 183.03 Bn 175.74 Bn 6.27 Bn 17.31 Bn
2 Stryker 129.38 Bn 126.50 Bn 3.81 Bn -1.51 Bn
3 Medtronic 108.86 Bn 99.64 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 47.66 Bn 43.99 Bn 1.29 Bn -451.20 Mn
6 Dexcom 28.64 Bn 27.52 Bn 750.30 Mn -25.00 Mn
7 GE HealthCare Technologies 28.55 Bn 26.27 Bn 1.98 Bn 21.00 Mn
8 Smith & Nephew 27.02 Bn 26.44 Bn - -
9 Koninklijke Philips 25.54 Bn 22.42 Bn 2.07 Bn -26.93 Mn
10 QuidelOrtho 1.15 Bn 1.01 Bn - 37.60 Mn

Historic Data

Download Data
DateValue
Mar 29, 2026 37.60 Mn
Mar 29, 2026 37.60 Mn
Dec 28, 2025 -11.10 Mn
Dec 28, 2025 -11.10 Mn
Sep 28, 2025 46.00 Mn
Sep 28, 2025 46.00 Mn
Jun 29, 2025 103.30 Mn
Jun 29, 2025 103.30 Mn
Mar 30, 2025 17.60 Mn
Mar 30, 2025 17.60 Mn
Dec 29, 2024 -68.90 Mn
Dec 29, 2024 -68.90 Mn
Sep 29, 2024 -26.30 Mn
Sep 29, 2024 -26.30 Mn
Jun 30, 2024 162.50 Mn
Jun 30, 2024 162.50 Mn
Mar 31, 2024 -18.50 Mn
Mar 31, 2024 -18.50 Mn
Dec 31, 2023 -57.80 Mn
Dec 31, 2023 -57.80 Mn